"Methods For Detecting Or Treating Glioblastoma Multiforme" in Patent Application Approval Process (USPTO 20240229144).

A patent application by inventors from Baylor Research Institute has been made available online for a method of detecting and treating glioblastoma multiforme (GBM), a type of brain cancer. The method involves determining the expression levels of specific biomarkers in a sample from the subject, which can be used for diagnosis, prognosis, and evaluation of GBM. This method has the potential to reduce the need for invasive brain biopsies and assist with imaging diagnosis and surveillance. The patent application also includes a kit for detecting the biomarkers and a method for making and amplifying cDNA from a biological sample. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)